FAL Duiven undertakes the manufacture of pharmaceutical solid dosage forms for human use, being coated and uncoated tablets, which are consequently supplied in bulk to third parties.
FAL Duiven does not have an in-house packaging facility. FAL Duiven included in its dossiers an independent local packaging company to handle the blistering and the packaging of its products. This service has been established to meet the requirements of various customers who specifically prefer to have from FAL Duiven the fully packed product.
FAL Duiven also undertakes the development of new products as well as the manufacture of pilot scale batches and bio-batches.
These activities are carried out under the GMP manufacturing license issued by the Ministry of Health of the Netherlands (Human Pharmaceuticals), which covers both licensed products and Investigational Medicinal Products (IMP). A controlled drug authorization is also held.